{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:05:29Z","timestamp":1794650729275,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","award":["grant EDUC2-08383"],"award-info":[{"award-number":["grant EDUC2-08383"]}],"id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["TRAN1-11544"],"award-info":[{"award-number":["TRAN1-11544"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA197359"],"award-info":[{"award-number":["1R01CA197359"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Immortalized, clonal\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/hb1.f3.cd\">HB1.F3.CD<\/jats:ext-link>\n                      21 human neural stem\/progenitor cells (NSCs), loaded with therapeutic cargo prior to intraperitoneal (IP) injection, have been shown to improve the delivery and efficacy of therapeutic agents in pre-clinical models of stage III ovarian cancer. In previous studies, the distribution and efficacy of the NSC-delivered cargo has been examined; however, the fate of the NSCs has not yet been explored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To monitor NSC tropism, we used an unconventional method of quantifying endocytosed gold nanorods to overcome the weaknesses of existing cell-tracking technologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here, we report efficient tumor tropism of\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/hb1.f3.cd\">HB1.F3.CD<\/jats:ext-link>\n                      21 NSCs, showing that they primarily distribute to the tumor stroma surrounding individual tumor foci within 3\u2009h after injection, reaching up to 95% of IP metastases without localizing to healthy tissue. Furthermore, we demonstrate that these NSCs are non-tumorigenic and non-immunogenic within the peritoneal setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Their efficient tropism, combined with their promising clinical safety features and potential for cost-effective scale-up, positions this NSC line as a practical, off-the-shelf platform to improve the delivery of a myriad of peritoneal cancer therapeutics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02226-8","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T09:06:08Z","timestamp":1616576768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Allogeneic human neural stem cells for improved therapeutic delivery to peritoneal ovarian cancer"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9069-0206","authenticated-orcid":false,"given":"Rachael","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Batalla-Covello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Wa","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Abdul-Majid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Aboody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"issue":"3","key":"2226_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177(3):1053\u201364.","journal-title":"Am J Pathol"},{"key":"2226_CR2","doi-asserted-by":"crossref","unstructured":"Ovarian cancer. Nat Rev Dis Primers. 2016 Aug 25;2:16062.","DOI":"10.1038\/nrdp.2016.62"},{"issue":"291","key":"2226_CR3","doi-asserted-by":"publisher","first-page":"291ra94","DOI":"10.1126\/scitranslmed.aaa5447","volume":"7","author":"B Huang","year":"2015","unstructured":"Huang B, Abraham WD, Zheng Y, Bustamante L\u00f3pez SC, Luo SS, Irvine DJ, et al. Sci Transl Med. 2015;7(291):291ra94.","journal-title":"Sci Transl Med"},{"issue":"9","key":"2226_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nm.2198","volume":"16","author":"MT Stephan","year":"2010","unstructured":"Stephan MT, Moon JJ, Um SH, Bershteyn A, Irvine DJ. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med. 2010;16(9):1035\u201341.","journal-title":"Nat Med"},{"issue":"12","key":"2226_CR5","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1021\/nl072209h","volume":"7","author":"M-R Choi","year":"2007","unstructured":"Choi M-R, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 2007;7(12):3759\u201365.","journal-title":"Nano Lett"},{"issue":"9","key":"2226_CR6","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1021\/nn202399w","volume":"5","author":"L Li","year":"2011","unstructured":"Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano. 2011;5(9):7462\u201370.","journal-title":"ACS Nano"},{"key":"2226_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jconrel.2014.06.015","volume":"191","author":"R Mooney","year":"2014","unstructured":"Mooney R, Weng Y, Garcia E, Bhojane S, Smith-Powell L, Kim SU, et al. Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy. J Control Release. 2014;191:82\u20139.","journal-title":"J Control Release"},{"issue":"6","key":"2226_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1634\/stemcells.2007-0887","volume":"26","author":"SE Kendall","year":"2008","unstructured":"Kendall SE, Najbauer J, Johnston HF, Metz MZ, Li S, Bowers M, et al. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells. 2008;26(6):1575\u201386.","journal-title":"Stem Cells"},{"issue":"1\u20132","key":"2226_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijpharm.2009.08.034","volume":"383","author":"N Mirahmadi","year":"2010","unstructured":"Mirahmadi N, Babaei MH, Vali AM, Dadashzadeh S. Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice. Int J Pharm. 2010;383(1\u20132):7\u201313.","journal-title":"Int J Pharm"},{"issue":"3","key":"2226_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1124\/jpet.108.140095","volume":"327","author":"Z Lu","year":"2008","unstructured":"Lu Z, Tsai M, Lu D, Wang J, Wientjes MG, Au JL-S. Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer. J Pharmacol Exp Ther. 2008;327(3):673\u201382.","journal-title":"J Pharmacol Exp Ther"},{"key":"2226_CR11","doi-asserted-by":"crossref","first-page":"720858","DOI":"10.1155\/2013\/720858","volume":"2013","author":"L De Smet","year":"2013","unstructured":"De Smet L, Ceelen W, Remon JP, Vervaet C. Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent. ScientificWorldJ. 2013;2013:720858.","journal-title":"ScientificWorldJ."},{"issue":"23","key":"2226_CR12","doi-asserted-by":"publisher","first-page":"7246","DOI":"10.1158\/1078-0432.CCR-09-1292","volume":"15","author":"EK Mader","year":"2009","unstructured":"Mader EK, Maeyama Y, Lin Y, Butler GW, Russell HM, Galanis E, et al. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin Cancer Res. 2009;15(23):7246\u201355.","journal-title":"Clin Cancer Res"},{"key":"2226_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1479-5876-11-20","volume":"11","author":"EK Mader","year":"2013","unstructured":"Mader EK, Butler G, Dowdy SC, Mariani A, Knutson KL, Federspiel MJ, et al. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J Transl Med. 2013;11:20.","journal-title":"J Transl Med"},{"issue":"6","key":"2226_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1021\/acs.bioconjchem.7b00237","volume":"28","author":"P Cao","year":"2017","unstructured":"Cao P, Mooney R, Tirughana R, Abidi W, Aramburo S, Flores L, et al. Intraperitoneal administration of neural stem cell-nanoparticle conjugates targets chemotherapy to ovarian tumors. Bioconjug Chem. 2017;28(6):1767\u201376.","journal-title":"Bioconjug Chem"},{"issue":"5","key":"2226_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1021\/acs.bioconjchem.9b00160","volume":"30","author":"P Tiet","year":"2019","unstructured":"Tiet P, Li J, Abidi W, Mooney R, Flores L, Aramburo S, et al. Silica coated paclitaxel nanocrystals enable neural stem cell loading for treatment of ovarian cancer. Bioconjug Chem. 2019;30(5):1415\u201324.","journal-title":"Bioconjug Chem"},{"issue":"12","key":"2226_CR16","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1158\/1078-0432.CCR-16-1518","volume":"23","author":"J Portnow","year":"2017","unstructured":"Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D\u2019Apuzzo M, et al. Neural stem cell-based anticancer gene therapy: a first-in-human study in recurrent high-grade glioma patients. Clin Cancer Res. 2017;23(12):2951\u201360.","journal-title":"Clin Cancer Res"},{"key":"2226_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.omtm.2018.05.006","volume":"10","author":"R Tirughana","year":"2018","unstructured":"Tirughana R, Metz MZ, Li Z, Hall C, Hsu D, Beltzer J, et al. GMP production and scale-up of adherent neural stem cells with a quantum cell expansion system. Mol Ther Methods Clin Dev. 2018;10:48\u201356.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2226_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.omto.2018.12.003","volume":"12","author":"R Mooney","year":"2019","unstructured":"Mooney R, Majid AA, Batalla-Covello J, Machado D, Liu X, Gonzaga J, et al. Enhanced delivery of oncolytic adenovirus by neural stem cells for treatment of metastatic ovarian cancer. Mol Ther Oncolytics. 2019;12:79\u201392.","journal-title":"Mol Ther Oncolytics."},{"issue":"24","key":"2226_CR19","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1002\/smll.201301111","volume":"9","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Morshed R, Cheng S-H, Tobias A, Auffinger B, Wainwright DA, et al. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy. Small. 2013;9(24):4123\u20139.","journal-title":"Small."},{"key":"2226_CR20","doi-asserted-by":"publisher","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010;(35):1488. https:\/\/doi.org\/10.3791\/1488.","DOI":"10.3791\/1488"},{"issue":"Pt 1","key":"2226_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2818.2005.01466.x","volume":"218","author":"JC Fiala","year":"2005","unstructured":"Fiala JC. Reconstruct: a free editor for serial section microscopy. J Microsc. 2005;218(Pt 1):52\u201361.","journal-title":"J Microsc"},{"issue":"12","key":"2226_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.5966\/sctm.2012-0177","volume":"2","author":"MZ Metz","year":"2013","unstructured":"Metz MZ, Gutova M, Lacey SF, Abramyants Y, Vo T, Gilchrist M, et al. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. Stem Cells Transl Med. 2013;2(12):983\u201392.","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"2226_CR23","doi-asserted-by":"publisher","first-page":"12450","DOI":"10.1021\/nn505147w","volume":"8","author":"R Mooney","year":"2014","unstructured":"Mooney R, Roma L, Zhao D, Van Haute D, Garcia E, Kim SU, et al. Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy. ACS Nano. 2014;8(12):12450\u201360.","journal-title":"ACS Nano"},{"issue":"7","key":"2226_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/adhm.201300003","volume":"2","author":"K Schnarr","year":"2013","unstructured":"Schnarr K, Mooney R, Weng Y, Zhao D, Garcia E, Armstrong B, et al. Gold nanoparticle-loaded neural stem cells for photothermal ablation of cancer. Adv Healthc Mater. 2013;2(7):976\u201382.","journal-title":"Adv Healthc Mater"},{"issue":"1\u20132","key":"2226_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10555-012-9351-2","volume":"31","author":"KL Sodek","year":"2012","unstructured":"Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ. Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev. 2012;31(1\u20132):397\u2013414.","journal-title":"Cancer Metastasis Rev"},{"issue":"13","key":"2226_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jnci\/djt141","volume":"105","author":"AU Ahmed","year":"2013","unstructured":"Ahmed AU, Thaci B, Tobias AL, Auffinger B, Zhang L, Cheng Y, et al. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. J Natl Cancer Inst. 2013;105(13):968\u201377.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2226_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-006-9121-5","volume":"79","author":"M Ziu","year":"2006","unstructured":"Ziu M, Schmidt NO, Cargioli TG, Aboody KS, Black PM, Carroll RS. Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J Neuro-Oncol. 2006;79(2):125\u201333.","journal-title":"J Neuro-Oncol"},{"key":"2226_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12931-014-0118-x","volume":"15","author":"MA Antunes","year":"2014","unstructured":"Antunes MA, Abreu SC, Cruz FF, Teixeira AC, Lopes-Pacheco M, Bandeira E, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res. 2014;15:118.","journal-title":"Respir Res"},{"key":"2226_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"issue":"2","key":"2226_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.mayocp.2013.10.020","volume":"89","author":"ED O\u2019Cearbhaill","year":"2014","unstructured":"O\u2019Cearbhaill ED, Ng KS, Karp JM. Emerging medical devices for minimally invasive cell therapy. Mayo Clin Proc. 2014;89(2):259\u201373.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2226_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354(1):34\u201343.","journal-title":"N Engl J Med"},{"issue":"4","key":"2226_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","volume":"28","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007;28(4):184\u201392.","journal-title":"Trends Immunol"},{"issue":"26","key":"2226_CR33","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1182\/blood-2009-05-224030","volume":"115","author":"F Lassailly","year":"2010","unstructured":"Lassailly F, Griessinger E, Bonnet D. \u201cMicroenvironmental contaminations\u201d induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking. Blood. 2010;115(26):5347\u201354.","journal-title":"Blood."},{"key":"2226_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.omto.2020.07.002","volume":"18","author":"M Hammad","year":"2020","unstructured":"Hammad M, Cornejo YR, Batalla-Covello J, Majid AA, Burke C, Liu Z, et al. Neural stem cells improve the delivery of oncolytic chimeric orthopoxvirus in a metastatic ovarian cancer model. Mol Ther Oncolytics. 2020;18:326\u201334.","journal-title":"Mol Ther Oncolytics"},{"issue":"6","key":"2226_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF00686048","volume":"25","author":"G Los","year":"1990","unstructured":"Los G, Mutsaers PH, Lenglet WJ, Baldew GS, McVie JG. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol. 1990;25(6):389\u201394.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"2226_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/02656736.2017.1312563","volume":"33","author":"C Carlier","year":"2017","unstructured":"Carlier C, Mathys A, De Jaeghere E, Steuperaert M, De Wever O, Ceelen W. Tumour tissue transport after intraperitoneal anticancer drug delivery. Int J Hyperth. 2017;33(5):534\u201342.","journal-title":"Int J Hyperth"},{"issue":"10","key":"2226_CR37","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"C-H Heldin","year":"2004","unstructured":"Heldin C-H, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806\u201313.","journal-title":"Nat Rev Cancer"},{"key":"2226_CR38","volume-title":"Intraperitoneal cancer therapy : principles and practice","author":"EA Levine","year":"2015","unstructured":"Levine EA, Ceelen WP. Intraperitoneal cancer therapy : principles and practice. Boca Raton: CRC Press; 2015."},{"key":"2226_CR39","doi-asserted-by":"publisher","first-page":"413076","DOI":"10.1155\/2015\/413076","volume":"2015","author":"NC Kampan","year":"2015","unstructured":"Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M. Paclitaxel and its evolving role in the management of ovarian cancer. Biomed Res Int. 2015;2015:413076.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2226_CR40","first-page":"871","volume":"290","author":"HJ Kuh","year":"1999","unstructured":"Kuh HJ, Jang SH, Wientjes MG, Weaver JR, Au JL. Determinants of paclitaxel penetration and accumulation in human solid tumor. J Pharmacol Exp Ther. 1999;290(2):871\u201380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2226_CR41","first-page":"1035","volume":"296","author":"SH Jang","year":"2001","unstructured":"Jang SH, Wientjes MG, Au JL. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. J Pharmacol Exp Ther. 2001;296(3):1035\u201342.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2226_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/jpet.107.121632","volume":"322","author":"D Lu","year":"2007","unstructured":"Lu D, Wientjes MG, Lu Z, Au JL-S. Tumor priming enhances delivery and efficacy of nanomedicines. J Pharmacol Exp Ther. 2007;322(1):80\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2226_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1010662413174","volume":"19","author":"SH Jang","year":"2001","unstructured":"Jang SH, Wientjes MG, Au JL. Determinants of paclitaxel uptake, accumulation and retention in solid tumors. Investig New Drugs. 2001;19(2):113\u201323.","journal-title":"Investig New Drugs"},{"issue":"11","key":"2226_CR44","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1172\/JCI87252","volume":"126","author":"M Yin","year":"2016","unstructured":"Yin M, Li X, Tan S, Zhou HJ, Ji W, Bellone S, et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016;126(11):4157\u201373.","journal-title":"J Clin Invest"},{"key":"2226_CR45","doi-asserted-by":"publisher","first-page":"345806","DOI":"10.4061\/2010\/345806","volume":"2010","author":"T Wilson","year":"2010","unstructured":"Wilson T, Stark C, Holmbom J, Rosling A, Kuusilehto A, Tirri T, et al. Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal. J Tissue Eng. 2010;2010:345806.","journal-title":"J Tissue Eng"},{"issue":"1","key":"2226_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1634\/stemcells.2006-0243","volume":"25","author":"TE Meyerrose","year":"2007","unstructured":"Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells. 2007;25(1):220\u20137.","journal-title":"Stem Cells"},{"issue":"1","key":"2226_CR47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1186\/s12885-018-4918-0","volume":"18","author":"T Gao","year":"2018","unstructured":"Gao T, Yu Y, Cong Q, Wang Y, Sun M, Yao L, et al. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor. BMC Cancer. 2018;18(1):999.","journal-title":"BMC Cancer"},{"key":"2226_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13287-016-0284-5","volume":"7","author":"N Bazhanov","year":"2016","unstructured":"Bazhanov N, Ylostalo JH, Bartosh TJ, Tiblow A, Mohammadipoor A, Foskett A, et al. Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs. Stem Cell Res Ther. 2016;7:27.","journal-title":"Stem Cell Res Ther"},{"issue":"23","key":"2226_CR49","doi-asserted-by":"publisher","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","volume":"97","author":"KS Aboody","year":"2000","unstructured":"Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97(23):12846\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"184","key":"2226_CR50","doi-asserted-by":"publisher","first-page":"184ra59","DOI":"10.1126\/scitranslmed.3005365","volume":"5","author":"KS Aboody","year":"2013","unstructured":"Aboody KS, Najbauer J, Metz MZ, D\u2019Apuzzo M, Gutova M, Annala AJ, et al. Neural stem cell-mediated enzyme\/prodrug therapy for glioma: preclinical studies. Sci Transl Med. 2013;5(184):184ra59.","journal-title":"Sci Transl Med"},{"issue":"11","key":"2226_CR51","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1046\/j.1365-2168.2002.02228.x","volume":"89","author":"M Bergstr\u00f6m","year":"2002","unstructured":"Bergstr\u00f6m M, Ivarsson ML, Holmdahl L. Peritoneal response to pneumoperitoneum and laparoscopic surgery. Br J Surg. 2002;89(11):1465\u20139.","journal-title":"Br J Surg"},{"issue":"1","key":"2226_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejso.2004.10.005","volume":"31","author":"SJ Oosterling","year":"2005","unstructured":"Oosterling SJ, van der Bij GJ, van Egmond M, van der Sijp JRM. Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol. 2005;31(1):29\u201337.","journal-title":"Eur J Surg Oncol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-021-02226-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T09:15:25Z","timestamp":1616577325000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2226"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02226-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-57439\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-57439\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.S.A., J.B., and R.M. disclose intellectual property with City of Hope and Harvard Patents. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}